Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with

Mark N Stein1,2, Jyoti Malhotra2, Rohinton S Tarapore3

  • 1Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA.

Abstract

Insights

Weekly oral ONC201, a DRD2 antagonist, is safe and well-tolerated in advanced solid tumors. This dosing schedule enhances anti-tumor immune responses, showing promise for future cancer therapies.

Area of Science:

  • Oncology
  • Pharmacology
  • Immunology

Background:

  • ONC201 is a small molecule antagonist targeting DRD2, a receptor overexpressed in various cancers.
  • Preclinical studies demonstrated ONC201's antitumor efficacy and immunomodulatory effects.
  • Previous trials established a recommended Phase II dose (RP2D) of 625 mg every three weeks.

Purpose of the Study:

  • To evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of weekly ONC201 administration.
  • To determine the RP2D for a weekly dosing schedule of ONC201 in patients with advanced solid tumors.
  • To assess the immunomodulatory effects of weekly ONC201 compared to every-three-week dosing.

Main Methods:

  • A Phase I dose-escalation study using a 3+3 design enrolled patients aged 18+ with advanced solid tumors refractory to standard treatments.
  • Dose levels ranged from 375 mg to 625 mg of ONC201, with a 21-day cycle and dose-limiting toxicity (DLT) window.
  • A dose expansion cohort of 11 patients confirmed the RP2D for weekly ONC201.

Main Results:

  • Twenty patients were enrolled; the RP2D was determined to be 625 mg weekly, with no DLTs, treatment discontinuations, or dose modifications due to toxicity.
  • PK profiles were consistent with established every-three-week dosing and remained stable between the first and fourth doses.
  • Weekly ONC201 induced serum prolactin, caspase-cleaved cytokeratin-18, integrated stress response, and Natural Killer cell infiltration; immune responses were heightened compared to every-three-week dosing.
  • Stable disease for over six months was observed in some prostate and endometrial cancer patients.

Conclusions:

  • Weekly oral administration of ONC201 is well-tolerated in patients with advanced solid tumors.
  • The weekly schedule enhances immunostimulatory activity compared to less frequent dosing.
  • These findings support further investigation of weekly ONC201 in clinical trials for cancer treatment.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
582
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Survey Safety01:28

Survey Safety

Surveying near highways, rough terrain, or power lines involves significant risks. Working along highways is particularly dangerous and requires the use of warning signs and flagmen. It is safest to avoid working directly on roads and use offsets whenever possible. When highway work is unavoidable, it must follow all safety guidelines. Surveyors should wear bright clothing, such as orange reflective vests, to ensure visibility to motorists, coworkers, and hunters. In construction zones, wearing...
380
Metallic Solids02:37

Metallic Solids

Metallic solids such as crystals of copper, aluminum, and iron are formed by metal atoms. The structure of metallic crystals is often described as a uniform distribution of atomic nuclei within a “sea” of delocalized electrons. The atoms within such a metallic solid are held together by a unique force known as metallic bonding that gives rise to many useful and varied bulk properties.
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
20.5K
Structures of Solids02:22

Structures of Solids

Solids in which the atoms, ions, or molecules are arranged in a definite repeating pattern are known as crystalline solids. Metals and ionic compounds typically form ordered, crystalline solids. A crystalline solid has a precise melting temperature because each atom or molecule of the same type is held in place with the same forces or energy. Amorphous solids or non-crystalline solids (or, sometimes, glasses) which lack an ordered internal structure and are randomly arranged. Substances that...
17.6K